Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emricasan in Decompensated NASH Cirrhosis
NCT03205345Phase 2Unknown
- Sponsor
- Conatus Pharmaceuticals Inc.
- Start
- Jun 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emricasan in Nonalcoholic Steatohepatitis Cirrhosis, sponsored by Conatus Pharmaceuticals Inc.. Status: unknown.
02
Drugs
emricasan
03
Conditions
Nonalcoholic Steatohepatitis Cirrhosis
Beyond the preview
Go deeper on NCT03205345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03205345.